We examined the mediating role of depression and anxiety on the relationship between fear of disease progression (FoP) and antiretroviral therapy (ART) adherence and the moderating role of social support in the FoP-depression/anxiety-ART adherence relationship in persons with HIV/AIDS (PWHA). 202 PWHA completed self-report measures. Simple mediation and moderated mediation analyses were performed. FoP was directly and negatively associated with ART adherence, and the mediating role of depression in this relationship was significant. Indirect effect of FoP mediated by anxiety on ART adherence was not significant. The moderating effect of social support was significant in the FoP-depression pathway, while the indirect effect of FoP on ART adherence mediated by depression was greatest at a higher level of social support and lower level of FoP. The results suggest the relevance of high FoP and depression-mediated FoP in ART adherence and social support may attenuate the negative impact of FoP.
BezabheWMChalmersLBereznickiLR, et al. (2016) Adherence to antiretroviral therapy and virologic failure: A meta-analysis. Medicine95(15): e3361.
2.
BlashillAJBedoyaCAMayerKH, et al. (2015) Psychosocial syndemics are additively associated with worse ART adherence in HIV-infected individuals. AIDS and Behavior19: 981–986.
3.
BrandtCZvolenskyMJWoodsSP, et al. (2017) Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literature. Clinical Psychology Review51: 164–184.
4.
CamposLNGuimarãesMDCRemienRH (2010) Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS and Behavior14(2): 289–299.
5.
CatzSLKellyJABogartLM, et al. (2000) Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology19(2): 124.
6.
ChangJGRohDKimCH (2015) The reliability and validity of the Korean version of medication adherence rating scale. Korean Journal of Psychopharmacology26(2): 43–49.
7.
CohenSWillsTA (1985) Stress, social support, and the buffering hypothesis. Psychological Bulletin98(2): 310–357.
8.
CristJVGrunfeldEA (2013) Factors reported to influence fear of recurrence in cancer patients: A systematic review. Psycho-Oncology22(5): 978–986.
9.
DiMatteoMR (2004) Social support and patient adherence to medical treatment: A meta-analysis. Health Psychology23(2): 207–218.
10.
DinkelAHerschbachP (2018) Fear of progression in cancer patients and survivors. In: GoerlingUMehnertA (eds) Psycho-Oncology. Cham: Springer, p.15.
11.
DinkelAKremsreiterKMarten-MittagB, et al. (2014) Comorbidity of fear of progression and anxiety disorders in cancer patients. General Hospital Psychiatry36(6): 613–619.
12.
FialkoLGaretyPAKuipersE, et al. (2008) A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophrenia Research100(1–3): 53–59.
13.
FisherABeekenRHeinrichM, et al. (2016) Health behaviours and fear of cancer recurrence in 10 969 colorectal cancer (CRC) patients. Psycho-Oncology25(12): 1434–1440.
14.
GonzalezJSPenedoFJAntoniMH, et al. (2004) Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology23(4): 413–418.
15.
HamiltonMMRazzanoLAMartinNB (2007) The relationship between type and quality of social support and HIV medication adherence. Journal of HIV/AIDS & Social Services6(1–2): 39–63.
16.
HarriganPRHoggRSDongWW, et al. (2005) Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. The Journal of Infectious Diseases191(3): 339–347.
17.
HawkinsNASmithTZhaoL, et al. (2010) Health-related behavior change after cancer: Results of the American Cancer Society’s studies of cancer survivors (SCS). Journal of Cancer Survivorship4(1): 20–32.
18.
HayesAF (2017) Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. New York, NY: Guilford Publications.
19.
HerschbachPBergPWaadtS, et al. (2010) Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychotherapy and Psychosomatics79(1): 31–38.
20.
IacorossiLGambalungaFFabiA, et al. (2018) Adherence to oral administration of endocrine treatment in patients with breast cancer: A qualitative study. Cancer Nursing41(1): E57–E63.
21.
IngersollK (2004) The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care16(2): 199–211.
22.
JeongDHHahmB-JSongYW, et al. (2020) A validation study of the Korean version of the Contextual Illness Support Scale. Korean Journal of Stress Research28(4): 269–275.
23.
KimJLeeEParkB-J, et al. (2018) Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009–2016: A nationwide study. Scientific Reports8(1): 3133.
24.
KwakkenbosLvan LankveldWGVonkMC, et al. (2012) Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem. Journal of Psychosomatic Research72(3): 199–204.
25.
LamPKNaar-KingSWrightK (2007) Social support and disclosure as predictors of mental health in HIV-positive youth. AIDS Patient Care and STDs21(1): 20–29.
26.
LamWYFrescoP (2015) Medication adherence measures: An overview. BioMed Research International2015: 217047.
27.
LangebeekNGisolfEHReissP, et al. (2014) Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: A meta-analysis. BMC Medicine12(1): 1–14.
28.
LebelSOzakinciGHumphrisG, et al. (2016) From normal response to clinical problem: Definition and clinical features of fear of cancer recurrence. Supportive Care in Cancer24(8): 3265–3268.
29.
LimaVDHarriganRBangsbergDR, et al. (2009) The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. Journal of Acquired Immune Deficiency Syndromes (1999)50(5): 529–536.
30.
LiuD-GWangS-SPengR-J, et al. (2011a) Interaction of social support and psychological stress on anxiety and depressive symptoms in breast cancer patients. Asian Pacific Journal of Cancer Prevention12(10): 2523–2529.
31.
LiuHGolinCEMillerLG, et al. (2001) A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine134(10): 968–977.
32.
LiuJPehC-XSimardS, et al. (2018) Beyond the fear that lingers: The interaction between fear of cancer recurrence and rumination in relation to depression and anxiety symptoms. Journal of Psychosomatic Research111: 120–126.
33.
LiuLPangRSunW, et al. (2013) Functional social support, psychological capital, and depressive and anxiety symptoms among people living with HIV/AIDS employed full-time. BMC Psychiatry13(1): 1–10.
34.
LiuYPérezMSchootmanM, et al. (2011b) Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Research and Treatment130(1): 165–173.
35.
McDowellTLSerovichJ (2007) The effect of perceived and actual social support on the mental health of HIV-positive persons. AIDS Care19(10): 1223–1229.
36.
McMahonJMBraksmajerAZhangC, et al. (2019) Syndemic factors associated with adherence to antiretroviral therapy among HIV-positive adult heterosexual men. AIDS Research and Therapy16(1): 1–10.
37.
MatsumotoSYamaokaKTakahashiK, et al. (2017) Social support as a key protective factor against depression in HIV-infected patients: Report from large HIV clinics in Hanoi, Vietnam. Scientific Reports7(1): 15489.
38.
MehnertAKochUSundermannC, et al. (2013) Predictors of fear of recurrence in patients one year after cancer rehabilitation: A prospective study. Acta Oncologica52(6): 1102–1109.
39.
MellinsCAHavensJFMcDonnellC, et al. (2009) Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care21(2): 168–177.
40.
MizunoYPurcellDWDawson-RoseC, et al. (2003) Correlates of depressive symptoms among HIV-positive injection drug users: The role of social support. AIDS Care15(5): 689–698.
41.
MorenoMde MatosMGCabralAJ (2014) Where does fear lead us: Antiretroviral treatment adherence in Maputo. Health6(7): 641-648.
42.
MuessigKELeGrandSHorvathKJ, et al. (2017) Recent mHealth interventions to support medication adherence among HIV-positive men who have sex with men. Current Opinion in HIV and AIDS12(5): 432.
43.
OhSMMinKJParkDB (1999) A study on the standardization of the hospital anxiety and depression scale for Koreans: A comparison of normal, depressed and anxious groups. Journal of Korean Neuropsychiatric Association38(2): 289–296.
44.
OrtegoCHuedo-MedinaTBLlorcaJ, et al. (2011) Adherence to highly active antiretroviral therapy (HAART): A meta-analysis. AIDS and Behavior15(7): 1381–1396.
45.
PakenhamKI (1998) Specification of social support behaviours and network dimensions along the HIV continuum for gay men. Patient Education and Counseling34(2): 147–157.
46.
PakenhamKIRinaldisM (2001) The role of illness, resources, appraisal, and coping strategies in adjustment to HIV/AIDS: The direct and buffering effects. Journal of Behavioral Medicine24(3): 259–279.
47.
PatersonDLSwindellsSMohrJ, et al. (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine133(1): 21–30.
48.
PennTMTrostZParkerR, et al. (2019) Social support buffers the negative influence of perceived injustice on pain interference in people living with HIV and chronic pain. Pain Reports4(2): e710.
49.
PolisSZablotska-ManosIZekryA, et al. (2017) Adherence to Hepatitis B antiviral therapy. Gastroenterology Nursing40(3): 239–246.
50.
RzeszutekMGruszczyńskaE (2018) Paradoxical effect of social support among people living with HIV: A diary study investigating the buffering hypothesis. Journal of Psychosomatic Research109: 25–31.
51.
Séguin LeclairCLebelSWestmaasJL (2019) The relationship between fear of cancer recurrence and health behaviors: A nationwide longitudinal study of cancer survivors. Health Psychology38(7): 596–605.
52.
SharpeLMichalowskiMRichmondB, et al. (2023) Fear of progression in chronic illnesses other than cancer: A systematic review and meta-analysis of a transdiagnostic construct. Health Psychology Review17: 301–320.
53.
ShimE-JShinY-WOhD-Y, et al. (2010) Increased fear of progression in cancer patients with recurrence. General Hospital Psychiatry32(2): 169–175.
54.
SiegelKLekasH-M (2002) AIDS as a chronic illness: Psychosocial implications. AIDS16: S69–S76.
55.
SimoniJMFrickPAHuangB (2006) A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychology25(1): 74–81.
56.
SinNLDiMatteoMR (2014) Depression treatment enhances adherence to antiretroviral therapy: A meta-analysis. Annals of Behavioral Medicine47(3): 259–269.
57.
SpringerSADushajAAzarMM (2012) The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: A systematic review. AIDS and Behavior16(8): 2119–2143.
ThewesBButowPBellM, et al. (2012) Fear of cancer recurrence in young women with a history of early-stage breast cancer: A cross-sectional study of prevalence and association with health behaviours. Supportive Care in Cancer20(11): 2651–2659.
60.
ThompsonKKulkarniJSergejewA (2000) Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research42(3): 241–247.
61.
TuckerJSBurnamMASherbourneCD, et al. (2003) Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. The American Journal of Medicine114(7): 573–580.
62.
UthmanOAMagidsonJFSafrenSA, et al. (2014) Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: A systematic review and meta-analysis. Current HIV/AIDS Reports11: 291–307.
63.
VolberdingPADeeksSG (2010) Antiretroviral therapy and management of HIV infection. The Lancet376(9734): 49–62.
64.
WarwickHMSalkovskisPM (1990) Hypochondriasis. Behaviour Research and Therapy28(2): 105–117.
65.
WatersEALiuYSchootmanM, et al. (2013) Worry about cancer progression and low perceived social support: Implications for quality of life among early-stage breast cancer patients. Annals of Behavioral Medicine45(1): 57–68.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
